Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Dexcom Inc (DXCM)

Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 28,447,036
  • Shares Outstanding, K 390,595
  • Annual Sales, $ 3,622 M
  • Annual Income, $ 541,500 K
  • EBIT $ 623 M
  • EBITDA $ 809 M
  • 60-Month Beta 1.17
  • Price/Sales 8.03
  • Price/Cash Flow 35.98
  • Price/Book 14.70

Options Overview Details

View History
  • Implied Volatility 39.92% ( -7.00%)
  • Historical Volatility 36.02%
  • IV Percentile 39%
  • IV Rank 24.98%
  • IV High 78.36% on 10/09/24
  • IV Low 27.12% on 05/16/24
  • Put/Call Vol Ratio 0.19
  • Today's Volume 14,781
  • Volume Avg (30-Day) 13,318
  • Put/Call OI Ratio 0.93
  • Today's Open Interest 181,497
  • Open Int (30-Day) 181,800

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.52
  • Number of Estimates 11
  • High Estimate 0.56
  • Low Estimate 0.48
  • Prior Year 0.50
  • Growth Rate Est. (year over year) +4.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
67.69 +15.13%
on 11/07/24
79.38 -1.81%
on 11/26/24
+4.50 (+6.13%)
since 10/25/24
3-Month
64.76 +20.35%
on 10/02/24
79.38 -1.81%
on 11/26/24
+4.27 (+5.80%)
since 08/26/24
52-Week
62.34 +25.02%
on 07/26/24
142.00 -45.11%
on 03/26/24
-35.01 (-31.00%)
since 11/24/23

Most Recent Stories

More News
These Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over

The Nasdaq-100 index tracks the largest 100 non-financial companies on the Nasdaq stock exchange. Although it's not a part of the U.S. stock market's big three indexes ( S&P 500, Nasdaq Composite , and...

COMP : 7.17 (+1.41%)
LULU : 318.84 (-2.41%)
INTC : 24.05 (-3.30%)
MRNA : 42.05 (-3.69%)
DXCM : 77.94 (+0.14%)
BIIB : 157.69 (-0.64%)
2 Superior Growth Stocks to Buy Right Now If You have $1,000 to Invest

It's not always easy to be a long-term investor, particularly when contending with the natural cyclicality that the stock market presents if you buy and hold through bull as well as bear markets.

RVLV : 38.80 (+2.16%)
DXCM : 77.94 (+0.14%)
Are Wall Street Analysts Predicting DexCom Stock Will Climb or Sink?

Despite DexCom’s underperformance relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.

XLV : 146.17 (+0.54%)
$SPX : 6,021.63 (+0.57%)
DXCM : 77.94 (+0.14%)
1 Stock to Buy Near Its 52-Week Low and Hold for 10 Years

This medical device company is down but not out.

DXCM : 77.94 (+0.14%)
Why DexCom Stock Flopped on Friday

Investors likely felt that with a compelling new product on the market, the company should have posted more meaningful growth.

DXCM : 77.94 (+0.14%)
Stocks Settle Mixed as Early Gains Fade on Mixed Corporate News

The S&P 500 Index ($SPX ) (SPY ) Friday closed down by -0.03%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.61%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +0.59%. Stocks...

AMAT : 173.20 (-0.77%)
SKX : 62.96 (-0.82%)
DLR : 194.02 (+0.62%)
$IUXX : 20,922.90 (+0.57%)
NYCB : 10.55 (-8.26%)
ZNZ24 : 110-185 (+0.23%)
OLN : 42.06 (-3.51%)
MHK : 139.92 (-3.52%)
GFS : 44.11 (-1.87%)
QCOM : 156.93 (-1.19%)
WDC : 73.02 (+5.18%)
TPR : 61.06 (+0.35%)
Stocks Rally as Chip Stocks Jump on Western Digital Earnings

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.86%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.38%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +1.53%. Stocks today are moderately...

AMAT : 173.20 (-0.77%)
SKX : 62.96 (-0.82%)
AVGO : 164.74 (-0.05%)
ADI : 219.05 (-2.03%)
DLR : 194.02 (+0.62%)
$IUXX : 20,922.90 (+0.57%)
NYCB : 10.55 (-8.26%)
ZNZ24 : 110-185 (+0.23%)
OLN : 42.06 (-3.51%)
MHK : 139.92 (-3.52%)
GFS : 44.11 (-1.87%)
QCOM : 156.93 (-1.19%)
Stocks Rise on Lower Bond Yields and Positive Earnings Results

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.54%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.38%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.84%. Stocks today are moderately...

AMAT : 173.20 (-0.77%)
SKX : 62.96 (-0.82%)
AVGO : 164.74 (-0.05%)
ADI : 219.05 (-2.03%)
DLR : 194.02 (+0.62%)
$IUXX : 20,922.90 (+0.57%)
NYCB : 10.55 (-8.26%)
ZNZ24 : 110-185 (+0.23%)
OLN : 42.06 (-3.51%)
MHK : 139.92 (-3.52%)
GFS : 44.11 (-1.87%)
QCOM : 156.93 (-1.19%)
DexCom (DXCM) Q3 2024 Earnings Call Transcript

DXCM earnings call for the period ending September 30, 2024.

DXCM : 77.94 (+0.14%)
DexCom: Q3 Earnings Snapshot

DexCom: Q3 Earnings Snapshot

DXCM : 77.94 (+0.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of...

See More

Key Turning Points

3rd Resistance Point 81.67
2nd Resistance Point 80.53
1st Resistance Point 79.23
Last Price 77.94
1st Support Level 76.79
2nd Support Level 75.65
3rd Support Level 74.35

See More

52-Week High 142.00
Fibonacci 61.8% 111.57
Fibonacci 50% 102.17
Fibonacci 38.2% 92.77
Last Price 77.94
52-Week Low 62.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar